Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study

被引:32
作者
Troeltzsch, Matthias [1 ]
Woodlock, Timothy [2 ,3 ]
Pianka, Alix [1 ]
Otto, Sven [1 ]
Troeltzsch, Markus [4 ]
Ehrenfeld, Michael [5 ]
Knoesel, Thomas [6 ]
机构
[1] Ludwig Maximilians Univ Munchen, Dept Oral & Maxillofacial Surg, Lindwurmstr 2a, D-80337 Munich, Germany
[2] Univ Rochester, Sch Med & Dent, Dept Med, Div Med Oncol & Hematol, Rochester, NY 14642 USA
[3] Unity Hlth Syst, Rochester, NY USA
[4] Georg August Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany
[5] Ludwig Maximilians Univ Munchen, Dept Oral & Maxillofacial Surg, Munich, Germany
[6] Ludwig Maximilians Univ Munchen, Dept Pathol, Munich, Germany
关键词
TUMOR-INFILTRATING LYMPHOCYTES; PD-L1; EXPRESSION; NECK-CANCER; CHECKPOINT INHIBITORS; CLINICAL ACTIVITY; T-CELLS; HEAD; BLOCKADE; B7-H1; ASSOCIATION;
D O I
10.1016/j.joms.2016.11.006
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: To examine oral squamous cell carcinoma (OSCC) specimens for programmed death ligand-1 (PD-L1) expression and presence of programmed death-1 (PD-1)-positive tumor-infiltrating lymphocytes (TILs) and to determine possible clinicopathologic implications. It was hypothesized that PD-L1 expression and PD-1-positive TIL presence in OSCC would have no clinical relevance. Materials and Methods: The authors implemented a retrospective cohort study design. The study cohort was chosen in compliance with predefined inclusion criteria. Demographic, clinical, and histopathologic data were gathered. Tissue microarrays were obtained from paraffin-embedded OSCC specimens and analyzed immunohistochemically for PD-L1 expression and PD-1-positive TIL infiltration. PD-L1 positivity of OSCC specimens served as the predictor variable and neck node metastasis served as the primary outcome variable. Descriptive and inferential statistics were computed and the significance level was set at a P value less than or equal to .05. Results: The study sample was composed of 88 patients (48 men, 40 women; mean age, 61.34 yr). Marked PD-L1 expression was detected in 29% of OSCC specimens (26 of 88) and 83% of specimens (73 of 88) exhibited a high rate of PD-1-positive TIL infiltration. PD-L1 positivity of OSCC samples was significantly associated with the anatomic origin of OSCC (P = .039), presence of cervical metastasis (P = .039), and high PD-L1-positive TIL infiltration (P = .033). Conclusion: A considerable proportion of OSCCs exhibited marked PD-L1 expression. This could be associated with clinical parameters. PD-L1 expression in OSCC might differ depending on its anatomic origin. PD-1-positive TILs could be detected in most OSCC specimens. These findings might indicate a potential role for the PD-1 and PD-L1 pathway in OSCC.(C) 2016 American Association of Oral and Maxillofacial Surgeons
引用
收藏
页码:969 / 977
页数:9
相关论文
共 40 条
[1]   When to use the Bonferroni correction [J].
Armstrong, Richard A. .
OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2014, 34 (05) :502-508
[2]   PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer [J].
Badoual, Cecile ;
Hans, Stephane ;
Merillon, Nathalie ;
Van Ryswick, Cordelia ;
Ravel, Patrice ;
Benhamouda, Nadine ;
Levionnois, Emeline ;
Nizard, Mevyn ;
Si-Mohamed, Ali ;
Besnier, Nicolas ;
Gey, Alain ;
Rotem-Yehudar, Rinat ;
Pere, Helene ;
Tran, Thi ;
Guerin, Coralie L. ;
Chauvat, Anne ;
Dransart, Estelle ;
Alanio, Cecile ;
Albert, Sebastien ;
Barry, Beatrix ;
Sandoval, Federico ;
Quintin-Colonna, Francoise ;
Bruneval, Patrick ;
Fridman, Wolf H. ;
Lemoine, Francois M. ;
Oudard, Stephane ;
Johannes, Ludger ;
Olive, Daniel ;
Brasnu, Daniel ;
Tartour, Eric .
CANCER RESEARCH, 2013, 73 (01) :128-138
[3]   T-cell coregulatory molecule expression in urothelial cell carcinoma: Clinicopathologic correlations and association with survival [J].
Boorjian, Stephen A. ;
Sheinin, Yuri ;
Crispen, Paul L. ;
Farmer, Sara A. ;
Lohse, Christine M. ;
Kuntz, Susan M. ;
Leibovich, Bradley C. ;
Kwon, Eugene D. ;
Frank, Igor .
CLINICAL CANCER RESEARCH, 2008, 14 (15) :4800-4808
[4]   CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition [J].
Buchbinder, Elizabeth I. ;
Desai, Anupam .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01) :98-106
[5]   Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma [J].
Cho, Young-Ah ;
Yoon, Hye-Jung ;
Lee, Jae-Il ;
Hong, Sam-Pyo ;
Hong, Seong-Doo .
ORAL ONCOLOGY, 2011, 47 (12) :1148-1153
[6]   PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients [J].
D'Incecco, A. ;
Andreozzi, M. ;
Ludovini, V. ;
Rossi, E. ;
Capodanno, A. ;
Landi, L. ;
Tibaldi, C. ;
Minuti, G. ;
Salvini, J. ;
Coppi, E. ;
Chella, A. ;
Fontanini, G. ;
Filice, M. E. ;
Tornillo, L. ;
Incensati, R. M. ;
Sani, S. ;
Crino, L. ;
Terracciano, L. ;
Cappuzzo, F. .
BRITISH JOURNAL OF CANCER, 2015, 112 (01) :95-102
[7]   Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma [J].
de Souza Malaspina, Tatiana Salles ;
Gasparoto, Thais Helena ;
Sales Nogueira Costa, Maria Renata ;
de Melo, Edgard Franco, Jr. ;
Valerio Ikoma, Maura Rosane ;
Damante, Jose Humberto ;
Cavassani, Karen Angelica ;
Garlet, Gustavo Pompermaier ;
da Silva, Joao Santana ;
Campanelli, Ana Paula .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) :965-974
[8]   A guide for preparing a patient-oriented research manuscript [J].
Dodson, Thomas B. .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 104 (03) :307-315
[9]  
Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
[10]   Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers [J].
Economopoulou, Panagiota ;
Kotsantis, Ioannis ;
Psyrri, Amanda .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (08)